Regulatory UpdatesAug 24, 2026•1 min read

FDA Recalls Product Due to CGMP Deviations

By the PharmaCountry team

The FDA has initiated a recall of a product because of deviations from current Good Manufacturing Practices (CGMP).

The U.S. Food and Drug Administration (FDA) has issued a recall for a pharmaceutical product after identifying deviations from current Good Manufacturing Practices (CGMP). The recall underscores the agency's focus on ensuring manufacturing compliance and product safety.

Compiled by the PharmaCountry team · Source: FDA.gov

Topics:#FDA #recall #CGMP #regulatory #pharmaceuticals